Back to Search
DREW HICKS, PHARMD
PHARMD
Pharmacist
NPI: 1114635737Individual
Specialties, Licenses & Credentials
Research & Publications (20)
The 76-gene signature defines high-risk patients that benefit from adjuvant tamoxifen therapy.
PMID 18821012·Breast Cancer Res Treat·2009
3-trial
Intravesical administration of plasminogen activator inhibitor type-1 inhibits in vivo bladder tumor invasion and progression.
PMID 19010488·J Urol·2009
7-preclinical
In vitro biomechanical evaluations of screw-bar-polymethylmethacrylate and pin-polymethylmethacrylate internal fixation implants used to stabilize the vertebral motion unit of the fourth and fifth cervical vertebrae in vertebral column specimens from dogs.
PMID 19496660·Am J Vet Res·2009
7-preclinical
Cation/proton antiporter complements of bacteria: why so large and diverse?
PMID 19682259·Mol Microbiol·2009
8-other
Experimental infection of serotine bats (Eptesicus serotinus) with European bat lyssavirus type 1a.
PMID 19515825·J Gen Virol·2009
7-preclinical
Genetic heterogeneity in HER2 testing in breast cancer: panel summary and guidelines.
PMID 19391661·Arch Pathol Lab Med·2009
6-review
HGF/Met signalling promotes PGE(2) biogenesis via regulation of COX-2 and 15-PGDH expression in colorectal cancer cells.
PMID 19638428·Carcinogenesis·2009
7-preclinical
TLE3 as a candidate biomarker of response to taxane therapy.
PMID 19309506·Breast Cancer Res·2009
8-other
[Molecular phenotypes of breast cancer and their clinical application].
PMID 19489219·Zhonghua Bing Li Xue Za Zhi·2009
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 200 WAL ST
SUMMERSVILLE, WV 26651 - Phone
- (304) 872-7039
Quick Facts
- NPI
- 1114635737
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile